CS logo
small CS logo
Southeast Eye Institute, P.A. dba Eye Associates of Pinellas

Pinellas Park, Florida, United States
Eye care center in Pinellas Park, Florida
9375 66th St N, Pinellas Park, FL 33782

About Southeast Eye Institute, P.A. dba Eye Associates of Pinellas


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Southeast Eye Institute, P.A. dba Eye Associates of Pinellas


During the past decade, Southeast Eye Institute, P.A. dba Eye Associates of Pinellas conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Southeast Eye Institute, P.A. dba Eye Associates of Pinellas" #1 collaborator was "National Eye Institute (NEI)" with 4 trials as a collaborator, "National Institutes of Health (NIH)" with 4 trials as a collaborator, "Regeneron Pharmaceuticals" with 2 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 1 trials as a collaborator and "Kowa Company, Ltd." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

Clinical Trials Conditions at Southeast Eye Institute, P.A. dba Eye Associates of Pinellas


According to Clinical.Site data, the most researched conditions in "Southeast Eye Institute, P.A. dba Eye Associates of Pinellas" are "Diabetic Macular Edema" (3 trials), "Diabetic Retinopathy" (2 trials), "Full-thickness Macular Holes (MH)" (1 trials), "Proliferative Diabetic Retinopathy" (1 trials) and "Vitreomacular Traction" (1 trials). Many other conditions were trialed in "Southeast Eye Institute, P.A. dba Eye Associates of Pinellas" in a lesser frequency.

Clinical Trials Intervention Types at Southeast Eye Institute, P.A. dba Eye Associates of Pinellas


Most popular intervention types in "Southeast Eye Institute, P.A. dba Eye Associates of Pinellas" are "Drug" (4 trials), "Device" (2 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "2-mg Intravitreous Aflibercept Injection" (1 trials), "Bevacizumab + Deferred Aflibercept Group" (1 trials), "Deferred aflibercept" (1 trials), "Deferred laser" (1 trials) and "Intraocular gas (C3F8)" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Southeast Eye Institute, P.A. dba Eye Associates of Pinellas


The vast majority of trials in "Southeast Eye Institute, P.A. dba Eye Associates of Pinellas" are 6 trials for "All" genders.

Clinical Trials Status at Southeast Eye Institute, P.A. dba Eye Associates of Pinellas


Currently, there are NaN active trials in "Southeast Eye Institute, P.A. dba Eye Associates of Pinellas". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Southeast Eye Institute, P.A. dba Eye Associates of Pinellas, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Southeast Eye Institute, P.A. dba Eye Associates of Pinellas, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".